Skip to main content

Table 1 The relationship between P3H4 expression and clinicopathological characteristics in the TCGA cohort (n = 389)

From: P3H4 is correlated with clinicopathological features and prognosis in bladder cancer

Characteristics Expression of P3H4 mRNA, number (%)
  High (n = 195) Low (n = 194) p value
Age at diagnosis, years 69.25 ± 10.18 66.39 ± 10.87 0.008
Gender 0.053
 Male 136 (69.74) 152 (78.35)  
 Female 59 (30.26) 42 (21.65)  
BMI 26.71 ± 4.78 27.42 ± 6.99 0.277
Race category 0.001
 White 163 (87.63) 145 (77.54)  
 Black or African American 13 (6.99) 9 (4.81)  
 Asian 10 (5.38) 33 (17.65)  
Angiolymphatic invasion 0.181
 Yes 77 (57.04) 64 (48.85)  
 No 58 (42.96) 67 (51.15)  
Extracapsular extension 0.937
 Yes 35 (44.30) 31 (43.66)  
 NO 44 (55.70) 40 (56.34)  
Karnofsky performance score 84.33 ± 12.46 80.67 ± 15.39 0.146
Histologic grade 0.001
 High 191 (98.45) 174 (90.63)  
 Low 3 (1.55) 18 (9.38)  
Lymph node metastasis 0.454
 Yes 59 (38.31) 53 (42.74)  
 No 95 (61.69) 71 (57.26)  
Tumor histologic subtype 0.011
 Non-papillary 141 (73.82) 119 (61.66)  
 Papillary 50 (26.18) 74 (38.34)  
Metastasis 0.154
 M0 79 (91.86) 110 (97.35)  
 M1 7 (8.14) 3 (2.65)  
AJCC stage 0.006
 I 0 (0) 1 (0.52)  
 II 49 (25.13) 79 (41.15)  
 III 75 (38.46) 55 (28.65)  
 IV 71 (36.41) 57 (29.69)  
  1. Boldface means p < 0.05